Annemarie M J Braamse1, Sietze T van Turenhout, Jochim S Terhaar Sive Droste, Gerrit H de Groot, René W M van der Hulst, Michael Klemt-Kropp, Sjoerd D Kuiken, Ruud J L F Loffeld, M Tessa Uiterwaal, Chris J J Mulder, Joost Dekker. 1. aDepartment of Psychiatry and EMGO Institute for Health and Care Research Departments of bGastroenterology and Hepatology cRehabilitation Medicine, VU University Medical Center dDepartment of Gastroenterology and Hepatology, Sint Lucas Andreas Hospital, Amsterdam eDepartment of Gastroenterology and Hepatology, Rode Kruis Hospital, Beverwijk fDepartment of Gastroenterology and Hepatology, Kennemer Gasthuis, Haarlem gDepartment of Gastroenterology and Hepatology, Medical Center Alkmaar, Alkmaar hDepartment of Gastroenterology and Hepatology, Zaans Medical Center, Zaandam iDepartment of Gastroenterology and Hepatology, Spaarne Hospital, Hoofddorp, The Netherlands.
Abstract
BACKGROUND: Up to 37% of colorectal cancer (CRC) survivors report depressive and anxiety symptoms. The identification of risk factors for depressive or anxiety symptoms might help focus supportive care resources on those patients most in need. The present study aims to explore which factors are associated with heightened anxiety or depression symptom severity. METHODS: In this cross-sectional study, individuals diagnosed with CRC 3.5 to 6 years ago completed questionnaires on sociodemographic information, medical comorbidities, anxiety symptoms (Beck Anxiety Inventory), and depressive symptoms (Inventory of Depressive Symptomatology). The general linear model analysis of covariance was used to identify factors associated with heightened anxiety or depressive symptom severity. RESULTS: The sample included 91 CRC survivors, 40.7% women, mean age 69.1 years. A minority of CRC survivors had moderate (3.4%) or severe (2.3%) anxiety symptoms, and moderate (7.7%) or severe (0%) depressive symptoms. Shorter time since diagnosis and higher number of comorbid diseases were associated with higher anxiety symptom severity. Female sex and higher number of comorbid diseases were associated with higher depressive symptom severity. CONCLUSION: From this explorative study, it follows that survivors with multiple comorbid diseases, shorter time since diagnosis, and female survivors might be at risk for higher anxiety and/or depressive symptom severity. Survivors with these characteristics might need extra monitoring.
BACKGROUND: Up to 37% of colorectal cancer (CRC) survivors report depressive and anxiety symptoms. The identification of risk factors for depressive or anxiety symptoms might help focus supportive care resources on those patients most in need. The present study aims to explore which factors are associated with heightened anxiety or depression symptom severity. METHODS: In this cross-sectional study, individuals diagnosed with CRC 3.5 to 6 years ago completed questionnaires on sociodemographic information, medical comorbidities, anxiety symptoms (Beck Anxiety Inventory), and depressive symptoms (Inventory of Depressive Symptomatology). The general linear model analysis of covariance was used to identify factors associated with heightened anxiety or depressive symptom severity. RESULTS: The sample included 91 CRC survivors, 40.7% women, mean age 69.1 years. A minority of CRC survivors had moderate (3.4%) or severe (2.3%) anxiety symptoms, and moderate (7.7%) or severe (0%) depressive symptoms. Shorter time since diagnosis and higher number of comorbid diseases were associated with higher anxiety symptom severity. Female sex and higher number of comorbid diseases were associated with higher depressive symptom severity. CONCLUSION: From this explorative study, it follows that survivors with multiple comorbid diseases, shorter time since diagnosis, and female survivors might be at risk for higher anxiety and/or depressive symptom severity. Survivors with these characteristics might need extra monitoring.
Authors: Patricia Nguyen; Ruth Heisey; Camille Quenneville; Elaine Goulbourne; Rumaisa Khan; Emma Rinaldo; Helen Chagigiorgis; Rebecca Shields; Carol Townsley Journal: Support Care Cancer Date: 2022-05-24 Impact factor: 3.359
Authors: Shawn M McClintock; Robin B Dail; Laura S Howe-Martin; Tara K Mann; Donald E Bailey Journal: Cancer Nurs Date: 2022-01-27 Impact factor: 2.760
Authors: Shirin ArdeshirRouhaniFard; Paul C Dinh; Patrick O Monahan; Sophie D Fossa; Robert Huddart; Chunkit Fung; Yiqing Song; Darren R Feldman; Robert J Hamilton; David J Vaughn; Neil E Martin; Christian Kollmannsberger; Lawrence Einhorn; Kurt Kroenke; Lois B Travis Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-04-13 Impact factor: 4.254
Authors: L Leermakers; S Döking; B Thewes; A M J Braamse; M F M Gielissen; J H W de Wilt; E H Collette; J Dekker; J B Prins Journal: BMC Cancer Date: 2018-07-18 Impact factor: 4.430
Authors: Markus W Haun; Laura Simon; Halina Sklenarova; Verena Zimmermann-Schlegel; Hans-Christoph Friederich; Mechthild Hartmann Journal: Cancer Med Date: 2021-06-02 Impact factor: 4.452